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Abstract
Despite the fact that diabetes and other non-communicable diseases represent a significant
proportion of the global burden of disease, proportionate global action has not occurred. A 2003
article reported on global constraints to the implementation of effective policies to curb non-
communicable disease epidemics. These constraints include a lack of global advocacy, insufficient
attention from funding agencies and governments, partnerships and interactions, capacity and
resources, and global norms and standards, as well as orientation of health services to acute care.
Building on these ideas, this paper will review the progress that has been made with regards to each
constraint, focusing on the International Diabetes Federation's Unite for Diabetes campaign and
United Nations resolution on diabetes to show how this event – driven by globalization – has
helped remove some of these barriers. Additional progress in diabetes and NCD prevention and
control is also highlighted. The paper concludes by outlining what still needs to happen for




Every 10 seconds, someone in the world dies of diabetes-
related causes, placing the gravity of the diabetes epidemic
at least on par with that of HIV/AIDs. In the same 10 sec-
onds, another two people are diagnosed with the disease
for the rest of their life [1] and may suffer increased mor-
bidity and reduced quality of life, premature death, and
large adverse economic effects due to higher healthcare
and non-healthcare costs. Diabetes causes an estimated
12–14 years of life lost to premature death. [2] In the
United States in 2002 people with diabetes spent six times
more money on healthcare than people without diabetes;
mostly due to costly complications like cardiovascular dis-
ease, renal failure, and blindness. Morbidity, mortality,
and quality of life for people living with diabetes in low-
or middle-income countries may decline further if insulin
and appropriate health care is neither available nor acces-
sible. Currently, 246 million people have diabetes, and if
no action is taken, this number will increase to over 380
million in the next 20 years. Approximately 5–10% of all
people with diabetes have type 1, while the remaining
90–95% accounts for type 2 diabetes, which is largely
related to lifestyle and responsible for most of the
increase. An additional 200 million people around the
world have impaired glucose tolerance, a precursor for
type 2 diabetes, and this figure is expected to rise to 420
million by 2025. [3]
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Once considered a "disease of affluence," diabetes now
places a significant burden on developing countries. Glo-
bally, diabetes affects 5.9% of the adult population, but in
many countries in Asia and the Pacific, diabetes affects up
to one-third of the population. 80% of the global diabetes
burden is in the developing world, and emerging econo-
mies are particularly susceptible, since undernourishment
and stunting in childhood often leads to later onset of dia-
betes; this, combined with rapidly changing environ-
ments due to the nutrition transition and urbanization,
puts future working-age populations at high risk. [4]
China and India alone make up 25% of the total diabetes
burden, and face large increases in the next two decades,
with 104% and 150% escalations, respectively. This will
have profound consequences on the two rapidly develop-
ing populous economies.
Global Consequences
Diabetes is of significance because of the social, economic
and health burden it places on countries, and on individ-
uals and their families. Costs of diabetes are manifested in
both direct and indirect costs that put pressure on individ-
uals, societies and governments. Direct costs include med-
ical costs for long-term care and complications; indirect
costs account for losses in productivity, coping mecha-
nisms, and the costs of quality of life, which affects indi-
viduals and families and is immeasurable. In many
countries, the cost of insulin and diabetes supplies far
exceeds annual incomes, leaving people with diabetes
unable to properly manage their condition, and suscepti-
ble to complications in the long-term. Treatment of com-
plications is more expensive than prevention or control,
and studies have shown that health care expenditure for
people with diabetes is five times higher than for people
without diabetes. [5] In low income populations in urban
India, annual income spent on diabetes-related health
care increased from 24.5% in 1998 to 34.0% in 2005,
93.6% of which is out-of-pocket. [6]
As the diabetes epidemic unfolds, individuals are being
affected at younger ages due to increased risk exposure.
Globally, type 2 diabetes disproportionately affects the
working age population; 46% of those affected are aged
40–59 years, and half of all diabetes-related deaths occur
in individuals under age 70. For families, diabetes can be
a death sentence and a straight path to poverty if the per-
son with diabetes is the sole breadwinner – disabilities
from diabetes complications can lead to productivity loss
and life-long care. The WHO estimates that China, the
Russian Federation and India will lose $558 billion, $303
billion, and $237 billion, respectively, in foregone
national income due to diabetes, stroke and heart disease
in the next decade. [7]
Despite these facts, diabetes – and most non-communica-
ble diseases (NCDs) – has been largely neglected, due to
lack of financial and human capital, lack of fully-
informed key decision makers, and orientation of health
systems toward acute care. [8] Donors tend to fund issues
that are more easily addressed, such as vaccines and treat-
ment of acute diseases, and want to see rapid results. In
developing countries where infectious diseases persist,
chronic diseases are viewed as secondary in importance.
Lack of up-to-date information and education are crucial
factors in gaining support for NCD prevention and con-
trol. Misconceptions still exist; NCDs are due to lifestyle
choices and should be the responsibility of the individual,
NCDs only affect the rich and the elderly, infectious dis-
ease rates far outweigh NCD rates – as illustrated above,
these beliefs are false. Furthermore, elected officials tend
to react to problems that have immediate solutions and
can produce results within their term. Diabetes by nature
requires long-term investment; prevention and control
efforts implemented today will only produce visible
results in one decade. The media also shapes how health
issues are framed and addressed: children dying of HIV/
AIDs or diarrheal diseases provide a more compelling
image than individuals affected by diabetes. However,
there need not be such polarization of the issues: NCD
prevention efforts have much to learn from infectious dis-
ease successes, and vice-a-versa.
Globalization as a Driver
Increasing diabetes rates are driven by factors outside of
the health sector. Globalization refers to the 'process of
increasing the connectivity and interdependence of the
world's markets and businesses', [9] as well as the increas-
ing movement of ideas, people, commerce and financial
capital. [10] This leads to changes in cultural norms, life-
style, food supply, and ideas. Although not a new phe-
nomenon, globalization's scale and pace are rapidly
increasing, due to improvements in IT and transportation,
and due to greater integration of supply chains.
Globalization facilitates the spread of three risk factors
(poor diet, physical inactivity, tobacco use) that lead to
four diseases (cardiovascular disease, some cancers,
chronic respiratory disease and diabetes) which cause
more than 50% of deaths worldwide. In 2001, diabetes
accounted for 19,996,000 disability-adjusted life years,
80% of which were in developing countries, especially in
East Asia and the Pacific. This represented a 250% increase
worldwide from 1990, and a 266% increase in low and
middle income countries. [2,11]
These risks are attributable to the nutrition transition,
accelerating technological advances that bring time-saving
gadgets and rapid methods of transportation that discour-
age physical activity, changes in workplaces and workGlobalization and Health 2008, 4:3 http://www.globalizationandhealth.com/content/4/1/3
Page 3 of 8
(page number not for citation purposes)
hours, increasingly aggressive global marketing cam-
paigns and urbanization. The nutrition transition refers to
the replacement of traditional diets high in fruits and veg-
etables with a diet high in calories, animal fat and vegeta-
ble oils, and processed foods, and is occurring in most
developing countries throughout the world. [12] Global
economic policies concerning agriculture, trade, invest-
ment and marketing affect what the world eats, as do glo-
bal food and health policies. [13] Trade liberalization has
led to increased supply, decreased prices and increased
marketing. [14] According to JP Morgan, globally "the
cost of a calorie (energy) has fallen dramatically over the
past couple of years on the back of fat products falling in
price by more than 50% over the past 50 years (carbohy-
drates to a lesser extent) while vegetables increased by
more than a third." [15] Additionally, increased access to
and affordability of energy-dense foods, relative to nutri-
ent rich foods, leads to consumption of these unhealthier
foods. Resulting high-calorie diets rich in fat and low in
fruits and vegetables, coupled with reduced energy
expenditure in urban environments especially and mar-
keting campaigns encouraging overconsumption portend
obesity, which leads to non-communicable diseases
(NCDs), including type 2 diabetes.
Although globalizing forces can result in adverse health
outcomes, health is vital to the future of globalization. In
almost every country throughout the world, health pro-
duces wealth, and wealth produces health. [16,17] A fail-
ure to invest now in health will be disastrous for countries
when today's children become the next generation of
workers. As emerging market countries integrate into the
global economy, the health and vitality of their workforce
is imperative. According to Steve Leeder and colleagues,
"Just at the time when developing countries' economies
have the opportunity to invest more of their capacity
because a brief window of lower dependency has opened,
the workforce that nations count on to exploit that oppor-
tunity is itself prematurely dying". [18] Such global prob-
lems require global and local solutions.
Global progress in diabetes prevention and 
control
Overcoming global constraints
A 2003 article outlined five constraints to effective global
policies to curb increasing NCD rates: a lack of global
advocacy, partnerships and interactions, capacity and
resources, global norms and standards, as well as a health
service orientation towards acute care. [19] The authors
noted that these constraints give powerful opposition to
policies and interventions for promotion of healthy eat-
ing and physical activity, and concluded that until the bar-
riers are overcome, progress will be slow for NCD
prevention and control. Table 1 summarizes these ideas.
Indeed, progress has been slow in gaining proportionate
responses to the diabetes pandemic. However, the recent,
ongoing Unite for Diabetes campaign, combined with
other global developments, mark progress in overcoming
these constraints and suggests future success in NCD pre-
vention and control. The campaign has united the global
diabetes community, and led to the passage of a UN Res-
olution on Diabetes (UNR) in December 2006. The fol-
lowing section describes the campaign, illuminating
progress that has been made in terms of the five con-
straints to global policies as a direct result (Table 2), and
highlights areas that still need to be addressed for globali-
zation to effectively prevent and control NCDs.
Unite for Diabetes campaign
The campaign
The Unite for Diabetes campaign and UNR was the brain-
child of 20 year old Clare Rosenfeld and her mother Kari
Rosenfeld, who realized three years ago that the diabetes
world needed more cohesion to ensure recognition and
adequate treatment and care for all people with diabetes.
Table 1: Global Responses and Progress in 2003
Global Response Progress in 2003 Example
Global advocacy "What there is tends to be fragmented and risk-factor or disease specific"
Partnerships and interactions "If widely implemented, changes [especially in food industry] could harness 
the benefits of globalization and promote health"
WHO Strategy for Diet and Physical 
Activity, some progress with food 
(Kraft) and alcohol industry
Capacity and resources "national capacity for non-communicable disease prevention and control is 
weak and the institutional response to capacity development has not kept 
pace with epidemiological transition"
NIH and Fogarty International Center
Global norms and standards "increasing need to establish global norms...treaties are not the solution to 
the complex issues related to nutrition transition or physical inactivity. 
Multistakeholder and intergovernmental mechanisms and other non-
binding measures are better options, especially in relation to children"
FCTC
Reorientation of health 
services
Prevention, treatment and palliative care not implemented in most 
countries; focus on acute careGlobalization and Health 2008, 4:3 http://www.globalizationandhealth.com/content/4/1/3
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Officially launched in June 2006, the IDF-led Unite for
Diabetes campaign aims to:
￿ Place diabetes on the global agenda
￿ Increase awareness of the disease and patient education
￿ Address poverty as a main obstacle to access to quality
healthcare and insulin
￿ Pass a UN Resolution on Diabetes, which calls on all
governments to create national plan for the prevention,
treatment and cure of diabetes.
The campaign has two main parts – a top-down approach
targeting major policymakers around the world, and a
bottom-up approach aiming to make 1 billion people
aware of diabetes and the campaign. According to C.K.
Prahalad, incorporating the 4 billion people living in pov-
erty (less than $2 per day) in profitable win-win engage-
ments can help to alleviate poverty and associated
problems, in this case access to healthcare and essential
diabetes medicines. One overarching goal is to become
more efficient – and thus more effective – as a group [20]
and to overcome barriers to prioritizing diabetes on a glo-
bal scale. The Unite for Diabetes symbol, a blue circle rep-
resenting unity and the color of the sky which unites us
all, is used to spread awareness of diabetes, similar to the
way in which red ribbons promote AIDS awareness and
recognition as a public health priority.
Global Advocacy
To address the bottom-up part of the campaign, a global
coalition of diabetes associations is engaged, as well as
two groups of youth: the Novo Nordisk Youth Panel
(NNYP) and IDF Youth Ambassadors.
NNYP is a group of nineteen young people – fourteen of
whom have diabetes – from twelve countries. The Panel's
contribution to the campaign is to spread awareness
amongst the targeted 1 billion people by creating
National Youth Panels of diabetes advocates in their
respective home countries, and through the internet. Pan-
elists have employed information campaigns on World
Diabetes Day, blogs that highlight the issues, press release,
newspaper articles and radio/television interviews, lobby-
ing and peer-to-peer communication to build support
among the public and among politicians. To date, a
National Youth Panel and website has been set up in
Spain, El Salvador hosted a diabetes fair that was attended
by Health Minister Dr. Guillermo Maza Brisuelas, who
pledged his support of the UNR, and in Italy one panelist
has spoken with important policymakers in the EU,
including Franco Frattini, the current vice-president of the
European Commission.
The IDF Ambassadors, 25 young people with diabetes
from developing and developed countries, met in Cape
Town, South Africa at the 2006 IDF conference to partici-
pate in global diabetes advocacy. Sponsored by Novo
Nordisk and the IDF, the Youth Ambassadors collabo-
rated with each other on how to best engage in diabetes
issues in their own countries as youth ambassadors, pre-
sented their conclusions at a conference session, engaged
Table 2: Global Responses and Progress resulting from the Unite for Diabetes campaign
Global Response What the Unite for Diabetes campaign adds Example/Achievement
Global advocacy Global coalition of 190 IDF member associations from 150+ 
countries
Campaign kits provided to members of the global diabetes 
community
Blue circle and pins for solidarity
Includes youth
Changing Diabetes Barometer allows for 
measurability of the diabetes pandemic, crucial 
for driving global awareness and action
Partnerships and interactions Collaboration between IDF and pharmaceutical companies 
[Novo Nordisk, GlaxoSmithKline, LifeScan, Lilly, Merck, Pfizer, 
Bayer HealthCare, Lloyds Pharmacy, Novartis, Sanofi Aventis, 
Abbott Diabetes Care]
Largest ever diabetes coalition of IDF member associations, 
professional societies, charities and industry
Novo Nordisk Changing Diabetes Leadership 
Forum brought together policymakers, 
government officials, international and patient 
organizations, healthcare professionals, people 
with diabetes and media from 20 countries to 
address diabetes needs
Capacity and resources Gives countries capacity and encouragement to develop national 
diabetes plans; resources should follow as countries place 
diabetes higher on agendas
Motivates global diabetes community to coordinate better
World Diabetes Foundation
The December 2006 passage of the UN 
Resolution will facilitate these processes.
Global norms and standards UNR urges all governments to create national diabetes plans for 
the prevention, treatment and care of diabetes
Reorientation of health 
services
UNR calls on all nations to develop national policies for the 
prevention, treatment and care of diabetesGlobalization and Health 2008, 4:3 http://www.globalizationandhealth.com/content/4/1/3
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with professionals at the conference, and created a video,
"Break the Silence," which illuminates challenges faced by
people with diabetes around the world. At the end of the
conference, the youth returned to their home countries to
tackle diabetes on a national level, spreading awareness
among policymakers and the general public, ensuring the
UNR's implementation in their own country based on
country-specific priorities.
Further advocacy was created, in part through these two
groups, on November 14, 2007, the first official World
Diabetes Day. The worldwide event was a celebration of
the campaign's success, and involved advocacy events at
the United Nations building in New York and other glo-
bal landmarks.
Partnerships and interactions
The campaign brought together the largest ever diabetes
coalition (190 IDF member associations, scientific and
professional diabetes societies, charitable foundations
and service organizations, industry and youth) and bene-
fited from a partnership between Novo Nordisk and the
IDF. Engagement and unity of so many diverse actors
from different backgrounds has the potential to solve
practical public health problems, as each brings unique
talents, resources, and perspectives to the table.
In September 2006, Novo Nordisk launched a Changing
Diabetes Bus, a global drive for change. The goal is to raise
awareness of diabetes and its social, humanitarian and
economic consequences on a one-and-a-half-year long
journey around five continents. The hope is to communi-
cate to important stakeholders the urgency of the diabetes
pandemic. [21] Novo Nordisk's involvement in the cam-
paign also stimulated competitive spirit in other pharma-
ceutical companies such as Merck, who then joined in as
well with resources for geocaching activities to foster cam-
paign awareness.
However, since most of the drivers of diabetes lay outside
of the health sector, future partnerships should strive to go
beyond pharmaceutical and medical groups. Partnerships
with industry can help to harness the benefits of globali-
zation and public health promotion, and should be culti-
vated. Recent successes include a recent partnership
between the Department of Health in the UK, Jamie
Oliver and Sainsbury's, which harnesses Sainsbury's cor-
porate strength and Oliver's immense popularity among
children to suggest what parents and children to promote
healthy family meals as a way of improving the health of
the nation. [22] In May 2006, collaboration between the
Alliance for a Healthier Generation (a partnership
between the William J. Clinton Foundation and the Amer-
ican Heart Association), the American Beverage Associa-
tion and the three largest soda companies in the world –
Coca-Cola, PepsiCo and Cadbury Schweppes led to an
agreement to ban soda sales in elementary and middle
schools in the United States, which was implemented in
late 2006. Moreover, Nike and Apple's unique collabora-
tion in the Nike+ system harnesses market innovation to
inspire physical activity among consumers. [23] With par-
ticular respect to a lack of availability and access to insulin
in many developing countries, collaboration and partner-
ships with pharmaceutical companies that can help
deliver essential medicines and health education to the
people who need it are crucial.
Capacity and resources, Global norms and standards
In many developing countries, national capacity is absent
or weak due to a strong focus on infectious diseases –
national capacity can be strengthened by global action, as
highlighted in a recent Nature article. [24]
On December 20, 2006, the United Nations General
Assembly passed the landmark resolution, co-sponsored
by Bangladesh and South Africa, the current leader of the
G77. In doing so, the UN recognized the global threat of
the diabetes epidemic and placed a NCD on their global
health agenda for the first time. The Resolution names the
current IDF World Diabetes Day, November 14th as a
United Nations Day to be observed every year starting in
2007, and calls on all nations to develop national policies
for the prevention, treatment and care of diabetes in line
with sustainable development of their healthcare systems.
The Resolution does not mobilize funds, but urges
national governments to allocate resources for diabetes
action.
With implementation, the UNR strengthens countries
with less responsive governments, and gives legitimacy to
national effects that might be undermined without a glo-
bal backdrop. The Framework Convention on Tobacco
Control (FCTC) and Global Strategy for Diet and Physical
Activity, which pulled together players from all over the
world, formed similar alliances that were met with suc-
cess. According to Yach et al., the FCTC created a global
forum to highlight issues, promotion of multilateral coor-
dination and domestic action, facilitation of the develop-
ment of national coalitions, and the mobilization of
NGOs, media and the general public. [25] The FCTC led
to UN system-wide approach to tobacco control and
national, complementary actions which would not have
been possible in the absence of a global alliance and the
synergistic effect of players from multiple sectors working
together. The passage of the UNR follows in the footsteps
of the FCTC; it has helped to develop capacity, and
national, complementary actions and resources will hope-
fully follow as diabetes is recognized as higher priority. It
will also lead to global norms and standards as all coun-
tries begin to develop harmonizing diabetes prioritizationGlobalization and Health 2008, 4:3 http://www.globalizationandhealth.com/content/4/1/3
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strategies. Still, no accepted list of essential drugs and
diagnostics for diabetes and other NCDs exists, suggesting
a critical area of neglect that needs to be addressed, since
high costs result from diagnosis as well as treatment, but
are rarely tackled together.
Health service reorientation
The UNR calls on all nations to develop national policies
for the prevention, treatment and care of diabetes in line
with sustainable development of their healthcare systems.
A key message is that diabetes care should be defined as a
human right. Insulin (as well as equipment and educa-
tion) is a basic tool for survival for people with diabetes
and is crucial to successful diabetes control strategies that
can prevent costly complications down the road. Addi-
tionally, patient education is cost saving, and is para-
mount to successful management and control of diabetes.
[26] Primary and secondary care centers should be acces-
sible and affordable, and national diabetes screening
guidelines should be implemented to ensure early detec-
tion and diagnosis and ongoing care. Monitoring of gov-
ernments (surveillance) is needed to a.) make sure
governments have a plan and follow through with it and
b.) allocate appropriate funds. Lastly, countries should
strive to increase human resources for prevention and
control of diabetes; India's Health Minister recently cre-
ated an effort to provide incentives and encourage Indian
physicians and public health professionals living abroad
to return to India; a recent review of global public health
schools shows a considerable a lack of NCD capacity-
building and research in developed and developing coun-
tries – an enormous barrier to improved prevention, con-
trol and management. [27]
Future progress
Much progress has been made, but much more remains to
be done. A key aspect of the campaign is that it is disease-
specific. The benefit is that it focuses attention directly on
diabetes, a condition that has historically received little
recognition, even compared to other NCDs like CVD.
However, future steps should closely align diabetes efforts
with other NCD and obesity efforts for maximum benefit
and unity. Even type 1 diabetes, which is not yet prevent-
able, is linked to CVD, blindness and chronic renal fail-
ure; advocates can benefit from global alliances with
advocates of conditions that share common risk factors
and complications. Governments should be encouraged
to address all lifestyle related chronic diseases: cardiovas-
cular diseases, cancers, respiratory diseases. Structural
emphasis on research and development, low cost sustain-
able interventions, and policy analysis should all be incor-
porated into these efforts. Global norms regarding
marketing to children, labeling of foods, and industry
incentives for producing acceptable fruit and vegetable-
based products at low cost could also help to encourage
healthier lifestyles and prevent diabetes.
More players – the WTO and others – should be included
in discussions as countries develop national diabetes pol-
icies, ensuring that trade and other policies complement
national health policies. Specifically, more industry play-
ers should be included in efforts. The private sector, espe-
cially food, sports, and retail industries are becoming
increasingly involved in obesity prevention and control,
which goes hand in hand with diabetes prevention and
control. Industry can – and should – engage in spreading
awareness of diabetes and other NCDs; many have
already begun. [28] There is an opportunity for the trade-
mark blue circle to be placed on packaging or other indus-
try-materials, aligning companies with the cause for
diabetes, and further spreading awareness of the Unite for
Diabetes campaign – a win-win partnership. A broader
alliance is more likely to generate the political support
needed to make real progress in diabetes prevention and
control.
Missed Opportunity?
Despite the campaign's success, lessons can be learned for
future improvements. A prolonged Unite for Diabetes
campaign could have produced much more media atten-
tion, public awareness, and policymaker support than it
did. Launched in June 2006, the campaign gained
momentum, but ended abruptly six months later with the
UNR's passing. Diabetes associations and groups around
the world reported on the campaign's success, but preach-
ing to the choir will not raise awareness among the gen-
eral public of diabetes as a global health priority. Media
attention in news sources around the world was absent,
with no major newspaper reporting on the passage of the
UNR. Incorporating multi-stakeholder involvement and
activism in the passage of the UNR could have gained
more buy-in, and potential for political support.
Certainly policy is what will create action by governments
around the world, but perhaps this could be facilitated by
increased awareness? Strengthening the bottom-up
approach can make policy change easier. Intractable chal-
lenges include a lack of political will, misconceptions
about the causes and consequences of diabetes, and lack
of funding for turning research into action and public
health practice, all of which could have been addressed
with a longer campaign.
Conclusion
Past literature has focused on globalization and spread of
unhealthy lifestyles as a negative player in global health.
Globalizing forces can also facilitate the spread of best
practice for diabetes prevention and control, and help toGlobalization and Health 2008, 4:3 http://www.globalizationandhealth.com/content/4/1/3
Page 7 of 8
(page number not for citation purposes)
overcome the five global constraints discussed in this
paper.
Harnessing the power of globalization has the potential to
create real change for diabetes communities throughout
the world, as countries with less capabilities benefit from
strong global coalitions. The Unite for Diabetes campaign
and subsequent passage of the UNR, as well as other
recent global initiatives, provides a clear example of glo-
balization's positive effect on health in the fight to place
diabetes higher on global health and political agendas,
and can be used as a model for future endeavors.
In addition to the Unite for Diabetes campaign and UNR,
much progress has recently been made for NCD preven-
tion and control, with more players stepping up to the
plate since 2006. Strong partnerships, resulting in
increased capacity and resources, have been formed, such
as the Ovations Chronic Disease Initiative and the 2007
launch of Community Interventions for Health, a multi-
national community-based program to reduce the risk fac-
tors for chronic diseases in China, India, Mexico and the
UK. [29,30] In November 2007, the Oxford Health Alli-
ance's Grand Challenges initiative's Phase 1 was com-
pleted, which has identified 20 global policy and research
priorities for addressing NCDs and formed the Grand
Challenges Global Partnership. [24] Many countries are
beginning to shift health systems to be more prevention-
focused; in the UK, for example, the government is taking
aggression action to address obesity and NCDs, and in
January 2008 the Indian Health Minister announced the
launch of a pilot National Diabetes Program.
These events, coupled with the Unite for Diabetes cam-
paign and passage of the UNR mark an important turning
point in viewing diabetes and other chronic diseases as
global health priorities, and hopefully will result in more
global initiatives, sustained funding increases, media and
policy attention, and to change attitudes and behaviors.
Although the UNR is only a piece of paper, its implemen-
tation will hopefully lead to real action that will also have
real impacts.
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